Veracyte Afirma Portal

Health And Fitness Business Society

The best matching results for Veracyte Afirma Portal are listed below, along with top pages, current status, FAQs, and comments. If you are facing any issues, please write detail in the comments section for the solution.

Updated: April 25, 2022

Afirma

https://www.afirma.com/

Current Status

Page Active

Last Checked

14 days ago

Check Now

Service Status Graph

Afirma.com

Most Visited Official Pages

A Genomic Sequencing ...

Implications of a suspicious ...

Clinical Validation of the ...

FAQs

How accurate is Afirma?

Afirma GEC test specificity is 52% (4), suggesting that just over half of the benign nodules are called GEC benign. Test PPV measures the fraction of “positive” calls by the test (e.g. Afirma GEC suspicious) that are correct. Afirma GEC test PPV is 37-38% amongst Bethesda III and IV nodules (4).

What does Afirma test for?

Afirma™ Gene Expression Classifier: a test for a group of molecular markers in thyroid biopsy specimens in order to determine the likelihood that a thyroid nodule is benign or cancerous. This test is performed by the company Veracyte Inc.

What is Afirma XA?

The Afirma Xpression Atlas (XA) (Veracyte, South San Francisco, California), which uses RNA sequencing to detect expressed variants and fusions, was launched in May 2018, and its analytical and clinical validation data for thyroid nodules were published subsequently.

2. Veracyte.com

Veracyte Portal

https://portal.veracyte.com/

You have to enable javascript in your browser to use an application built with Vaadin.

DISLIKE

REPORT